Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands |
3 Months Ended |
Jan. 31, 2016 |
Jan. 31, 2015 |
| Cash flows from operating activities: |
|
|
| Net loss |
$ (11,779)
|
$ (4,154)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Share-based compensation |
858
|
761
|
| Gain from change in fair value of embedded derivatives |
(84)
|
(39)
|
| Depreciation |
1,151
|
963
|
| Interest expense on preferred stock obligation |
430
|
480
|
| Unrealized foreign exchange gains |
(845)
|
(1,513)
|
| Other non-cash transactions, net |
203
|
(125)
|
| Decrease (increase) in operating assets: |
|
|
| Accounts receivable |
16,493
|
3,747
|
| Inventories |
5,478
|
(725)
|
| Project assets |
(8,939)
|
(4,928)
|
| Other assets |
120
|
(2,857)
|
| Increase (decrease) in operating liabilities: |
|
|
| Accounts payable |
(1,141)
|
(468)
|
| Accrued liabilities |
9,972
|
(131)
|
| Deferred revenue |
(3,321)
|
6,718
|
| Net cash provided by (used in) operating activities |
8,596
|
(2,271)
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
(1,314)
|
(1,616)
|
| Project asset expenditures |
(2,044)
|
0
|
| Net cash used in investing activities |
(3,358)
|
(1,616)
|
| Cash flows from financing activities: |
|
|
| Repayment of debt |
(8,916)
|
(121)
|
| Proceeds from debt |
20,102
|
0
|
| Increase in restricted cash and cash equivalents |
(10,387)
|
(2,144)
|
| Payment of preferred dividends and return of capital |
(1,033)
|
(1,094)
|
| Proceeds from sale of common stock, net of registration fees |
13,306
|
8,488
|
| Net cash provided by financing activities |
13,072
|
5,129
|
| Effects on cash from changes in foreign currency rates |
(218)
|
(288)
|
| Net increase in cash and cash equivalents |
18,092
|
954
|
| Cash and cash equivalents-beginning of period |
58,852
|
83,710
|
| Cash and cash equivalents-end of period |
76,944
|
84,664
|
| Supplemental cash flow disclosures: |
|
|
| Cash interest paid |
359
|
155
|
| Noncash financing and investing activity: |
|
|
| Common stock issued for Employee Stock Purchase Plan in settlement of prior year accrued employee contributions |
105
|
168
|
| Accrued grant awards |
1,099
|
0
|
| Accrued Sale of Common Stock, cash received in subsequent period |
$ 475
|
$ 33
|